Attached files
| file | filename |
|---|---|
| 8-K/A - 8-K/A - SANGAMO THERAPEUTICS, INC | sgmo-8ka_20181101.htm |
| EX-99.3 - EX-99.3 - SANGAMO THERAPEUTICS, INC | sgmo-ex993_6.htm |
| EX-99.2 - EX-99.2 - SANGAMO THERAPEUTICS, INC | sgmo-ex992_8.htm |
| EX-99.1 - EX-99.1 - SANGAMO THERAPEUTICS, INC | sgmo-ex991_7.htm |
CONSENT OF INDEPENDENT AUDITOR
We consent to the incorporation by reference in the following Registration Statements:
1. Registration Statements (Forms S-8 No. 333-166220, 333-189621, 333-206173, 333-221827, and 333-225552) pertaining to the Amended and Restated 2013 Stock Incentive Plan, 2010 Employee Stock Purchase Plan, and 2018 Equity Incentive Plan of Sangamo Therapeutics, Inc., and
2. Registration Statements (Forms S-3 No. 333-218294 and 333-224418) and related prospectuses of Sangamo Therapeutics, Inc.;
of our report dated December 7, 2018, with respect to the audited financial statements of TxCell S.A. included in this Current Report on Form 8-K/A of Sangamo Therapeutics, Inc. dated January 4, 2019.
January 3, 2019